Currently, there are 381.79M common shares owned by the public and among those 365.27M shares have been available to trade.
The company’s stock has a 5-day price change of -4.14% and 62.90% over the past three months. VRT shares are trading 67.96% year to date (YTD), with the 12-month market performance up to 548.99% higher. It has a 12-month low price of $11.95 and touched a high of $88.69 over the same period. VRT has an average intraday trading volume of 7.97 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -1.12%, 12.08%, and 69.86% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Vertiv Holdings Co (NYSE: VRT) shares accounts for 88.82% of the company’s 381.79M shares outstanding.
It has a market capitalization of $30.81B and a beta (3y monthly) value of 1.59. The stock’s trailing 12-month PE ratio is 68.57, while the earnings-per-share (ttm) stands at $1.18. The company has a PEG of 2.57 and a Quick Ratio of 1.35 with the debt-to-equity ratio at 1.55. Price movements for the stock have been influenced by the stock’s volatility, which stands at 5.98% over the week and 5.25% over the month.
Analysts forecast that Vertiv Holdings Co (VRT) will achieve an EPS of $Vaxart, Inc. – Common Stock for the current quarter, $0.91 for the next quarter and $Stocks for Type. The lowest estimate earnings-per-share for the quarter is $Vertex Pharmaceuticals Incorpor while analysts give the company a high EPS estimate of $Vanguard Total World Stock Inde. Comparatively, EPS for the current quarter was $Vertiv Holdings, LLC a year ago. Earnings per share for the fiscal year are expected to increase by 29.47%, and 26.68% over the next financial year. EPS should shrink at an annualized rate of 26.70% over the next five years, compared to 82.85% over the past 5-year period.
Looking at the support for the VRT, a number of firms have released research notes about the stock. Oppenheimer stated their Outperform rating for the stock in a research note on April 05, 2024, with the firm’s price target at $96. BofA Securities coverage for the Vertiv Holdings Co (VRT) stock in a research note released on August 02, 2023 offered a Buy rating with a price target of $40. Vertical Research was of a view on June 09, 2023 that the stock is Buy, while Cowen gave the stock Outperform rating on October 27, 2022, issuing a price target of $11.75- $20. JP Morgan on their part issued Overweight rating on April 01, 2022.
